IBDEI3AK ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,52531,1,4,0)
;;=4^I12.0
;;^UTILITY(U,$J,358.3,52531,2)
;;=^5007065
;;^UTILITY(U,$J,358.3,52532,0)
;;=I12.9^^194^2541^4
;;^UTILITY(U,$J,358.3,52532,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52532,1,3,0)
;;=3^Hypertensive CKD w/ Stage 1-4 CKD
;;^UTILITY(U,$J,358.3,52532,1,4,0)
;;=4^I12.9
;;^UTILITY(U,$J,358.3,52532,2)
;;=^5007066
;;^UTILITY(U,$J,358.3,52533,0)
;;=I13.0^^194^2541^8
;;^UTILITY(U,$J,358.3,52533,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52533,1,3,0)
;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 1-4 CKD
;;^UTILITY(U,$J,358.3,52533,1,4,0)
;;=4^I13.0
;;^UTILITY(U,$J,358.3,52533,2)
;;=^5007067
;;^UTILITY(U,$J,358.3,52534,0)
;;=I13.10^^194^2541^10
;;^UTILITY(U,$J,358.3,52534,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52534,1,3,0)
;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 1-4 CKD
;;^UTILITY(U,$J,358.3,52534,1,4,0)
;;=4^I13.10
;;^UTILITY(U,$J,358.3,52534,2)
;;=^5007068
;;^UTILITY(U,$J,358.3,52535,0)
;;=I13.11^^194^2541^11
;;^UTILITY(U,$J,358.3,52535,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52535,1,3,0)
;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 5 CKD/ESRD
;;^UTILITY(U,$J,358.3,52535,1,4,0)
;;=4^I13.11
;;^UTILITY(U,$J,358.3,52535,2)
;;=^5007069
;;^UTILITY(U,$J,358.3,52536,0)
;;=I13.2^^194^2541^9
;;^UTILITY(U,$J,358.3,52536,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52536,1,3,0)
;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 5 CKD/ESRD
;;^UTILITY(U,$J,358.3,52536,1,4,0)
;;=4^I13.2
;;^UTILITY(U,$J,358.3,52536,2)
;;=^5007070
;;^UTILITY(U,$J,358.3,52537,0)
;;=I15.0^^194^2541^15
;;^UTILITY(U,$J,358.3,52537,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52537,1,3,0)
;;=3^Renovascular Hypertension
;;^UTILITY(U,$J,358.3,52537,1,4,0)
;;=4^I15.0
;;^UTILITY(U,$J,358.3,52537,2)
;;=^5007071
;;^UTILITY(U,$J,358.3,52538,0)
;;=I15.1^^194^2541^3
;;^UTILITY(U,$J,358.3,52538,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52538,1,3,0)
;;=3^Hypertension Secondary to Oth Renal Disorders
;;^UTILITY(U,$J,358.3,52538,1,4,0)
;;=4^I15.1
;;^UTILITY(U,$J,358.3,52538,2)
;;=^5007072
;;^UTILITY(U,$J,358.3,52539,0)
;;=I15.2^^194^2541^2
;;^UTILITY(U,$J,358.3,52539,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52539,1,3,0)
;;=3^Hypertension Secondary to Endocrine Disorders
;;^UTILITY(U,$J,358.3,52539,1,4,0)
;;=4^I15.2
;;^UTILITY(U,$J,358.3,52539,2)
;;=^5007073
;;^UTILITY(U,$J,358.3,52540,0)
;;=I15.8^^194^2541^16
;;^UTILITY(U,$J,358.3,52540,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52540,1,3,0)
;;=3^Secondary Hypertension,Oth
;;^UTILITY(U,$J,358.3,52540,1,4,0)
;;=4^I15.8
;;^UTILITY(U,$J,358.3,52540,2)
;;=^5007074
;;^UTILITY(U,$J,358.3,52541,0)
;;=I15.9^^194^2541^17
;;^UTILITY(U,$J,358.3,52541,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52541,1,3,0)
;;=3^Secondary Hypertension,Unspec
;;^UTILITY(U,$J,358.3,52541,1,4,0)
;;=4^I15.9
;;^UTILITY(U,$J,358.3,52541,2)
;;=^5007075
;;^UTILITY(U,$J,358.3,52542,0)
;;=I16.0^^194^2541^14
;;^UTILITY(U,$J,358.3,52542,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52542,1,3,0)
;;=3^Hypertensive Urgency
;;^UTILITY(U,$J,358.3,52542,1,4,0)
;;=4^I16.0
;;^UTILITY(U,$J,358.3,52542,2)
;;=^8133013
;;^UTILITY(U,$J,358.3,52543,0)
;;=I16.1^^194^2541^7
;;^UTILITY(U,$J,358.3,52543,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,52543,1,3,0)
;;=3^Hypertensive Emergency
;;^UTILITY(U,$J,358.3,52543,1,4,0)
;;=4^I16.1
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3AK 3785 printed Apr 09, 2024@20:52:14 Page 2
IBDEI3AK ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,52531,1,4,0)
+2 ;;=4^I12.0
+3 ;;^UTILITY(U,$J,358.3,52531,2)
+4 ;;=^5007065
+5 ;;^UTILITY(U,$J,358.3,52532,0)
+6 ;;=I12.9^^194^2541^4
+7 ;;^UTILITY(U,$J,358.3,52532,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,52532,1,3,0)
+10 ;;=3^Hypertensive CKD w/ Stage 1-4 CKD
+11 ;;^UTILITY(U,$J,358.3,52532,1,4,0)
+12 ;;=4^I12.9
+13 ;;^UTILITY(U,$J,358.3,52532,2)
+14 ;;=^5007066
+15 ;;^UTILITY(U,$J,358.3,52533,0)
+16 ;;=I13.0^^194^2541^8
+17 ;;^UTILITY(U,$J,358.3,52533,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,52533,1,3,0)
+20 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 1-4 CKD
+21 ;;^UTILITY(U,$J,358.3,52533,1,4,0)
+22 ;;=4^I13.0
+23 ;;^UTILITY(U,$J,358.3,52533,2)
+24 ;;=^5007067
+25 ;;^UTILITY(U,$J,358.3,52534,0)
+26 ;;=I13.10^^194^2541^10
+27 ;;^UTILITY(U,$J,358.3,52534,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,52534,1,3,0)
+30 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 1-4 CKD
+31 ;;^UTILITY(U,$J,358.3,52534,1,4,0)
+32 ;;=4^I13.10
+33 ;;^UTILITY(U,$J,358.3,52534,2)
+34 ;;=^5007068
+35 ;;^UTILITY(U,$J,358.3,52535,0)
+36 ;;=I13.11^^194^2541^11
+37 ;;^UTILITY(U,$J,358.3,52535,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,52535,1,3,0)
+40 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 5 CKD/ESRD
+41 ;;^UTILITY(U,$J,358.3,52535,1,4,0)
+42 ;;=4^I13.11
+43 ;;^UTILITY(U,$J,358.3,52535,2)
+44 ;;=^5007069
+45 ;;^UTILITY(U,$J,358.3,52536,0)
+46 ;;=I13.2^^194^2541^9
+47 ;;^UTILITY(U,$J,358.3,52536,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,52536,1,3,0)
+50 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 5 CKD/ESRD
+51 ;;^UTILITY(U,$J,358.3,52536,1,4,0)
+52 ;;=4^I13.2
+53 ;;^UTILITY(U,$J,358.3,52536,2)
+54 ;;=^5007070
+55 ;;^UTILITY(U,$J,358.3,52537,0)
+56 ;;=I15.0^^194^2541^15
+57 ;;^UTILITY(U,$J,358.3,52537,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,52537,1,3,0)
+60 ;;=3^Renovascular Hypertension
+61 ;;^UTILITY(U,$J,358.3,52537,1,4,0)
+62 ;;=4^I15.0
+63 ;;^UTILITY(U,$J,358.3,52537,2)
+64 ;;=^5007071
+65 ;;^UTILITY(U,$J,358.3,52538,0)
+66 ;;=I15.1^^194^2541^3
+67 ;;^UTILITY(U,$J,358.3,52538,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,52538,1,3,0)
+70 ;;=3^Hypertension Secondary to Oth Renal Disorders
+71 ;;^UTILITY(U,$J,358.3,52538,1,4,0)
+72 ;;=4^I15.1
+73 ;;^UTILITY(U,$J,358.3,52538,2)
+74 ;;=^5007072
+75 ;;^UTILITY(U,$J,358.3,52539,0)
+76 ;;=I15.2^^194^2541^2
+77 ;;^UTILITY(U,$J,358.3,52539,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,52539,1,3,0)
+80 ;;=3^Hypertension Secondary to Endocrine Disorders
+81 ;;^UTILITY(U,$J,358.3,52539,1,4,0)
+82 ;;=4^I15.2
+83 ;;^UTILITY(U,$J,358.3,52539,2)
+84 ;;=^5007073
+85 ;;^UTILITY(U,$J,358.3,52540,0)
+86 ;;=I15.8^^194^2541^16
+87 ;;^UTILITY(U,$J,358.3,52540,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,52540,1,3,0)
+90 ;;=3^Secondary Hypertension,Oth
+91 ;;^UTILITY(U,$J,358.3,52540,1,4,0)
+92 ;;=4^I15.8
+93 ;;^UTILITY(U,$J,358.3,52540,2)
+94 ;;=^5007074
+95 ;;^UTILITY(U,$J,358.3,52541,0)
+96 ;;=I15.9^^194^2541^17
+97 ;;^UTILITY(U,$J,358.3,52541,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,52541,1,3,0)
+100 ;;=3^Secondary Hypertension,Unspec
+101 ;;^UTILITY(U,$J,358.3,52541,1,4,0)
+102 ;;=4^I15.9
+103 ;;^UTILITY(U,$J,358.3,52541,2)
+104 ;;=^5007075
+105 ;;^UTILITY(U,$J,358.3,52542,0)
+106 ;;=I16.0^^194^2541^14
+107 ;;^UTILITY(U,$J,358.3,52542,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,52542,1,3,0)
+110 ;;=3^Hypertensive Urgency
+111 ;;^UTILITY(U,$J,358.3,52542,1,4,0)
+112 ;;=4^I16.0
+113 ;;^UTILITY(U,$J,358.3,52542,2)
+114 ;;=^8133013
+115 ;;^UTILITY(U,$J,358.3,52543,0)
+116 ;;=I16.1^^194^2541^7
+117 ;;^UTILITY(U,$J,358.3,52543,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,52543,1,3,0)
+120 ;;=3^Hypertensive Emergency
+121 ;;^UTILITY(U,$J,358.3,52543,1,4,0)
+122 ;;=4^I16.1
